- Global Pharma News & Resources

Animal Livestock Drugs Market is Growing Rapidly With Value of USD 51.69 billion by 2029

DBMR team makes use of simple language and easy to understand statistical images to provide thorough information and in-depth data on the Healthcare industry and Animal Livestock Drugs market. The company profiles of all the key players and brands that are dominating the market have been taken into consideration here. The report also shares gross margin, market share, attractiveness index, and value and volume growth of all of the segments studied by the analysts. The report provides players with crucial information and suggests result-oriented tactics to gain a competitive edge in the worldwide market. Important industry trends, market size, market share estimates are analysed and mentioned in the realistic Animal Livestock Drugs market research report.

An all-inclusive Animal Livestock Drugs market report identifies, estimates, and analyses the emerging trends along with major drivers, restraints, challenges and opportunities in the market. Estimations of CAGR values, market drivers and market restraints helps businesses decide upon several strategies. The use of proven tools such as SWOT analysis and Porter’s Five Forces analysis are very helpful in creating such a top-notch report. The research and analysis carried out in the superior Animal Livestock Drugs report helps clients predict investment in an emerging market, expansion of market share or success of a new product with the help of global market research analysis.

Some of The Major Companies That Are Covered In This Report: Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland), Mallinckrodt (US), Elanco (US), Boehringer Ingelheim International GmbH. (Germany), GlaxoSmithKline plc (UK), Novartis AG (Switzerland), Bayer AG (Germany), Eli Lilly and Company (US), Merck & Co., Inc. (US), AstraZeneca (UK), Johnson & Johnson Private Limited (US), Virbac (France), Vetoquinol (France), Zoetis (US), Ceva (France), Bimeda, Inc. (US), Dechra Pharmaceuticals PLC (UK)

Get Sample Report + All Related Graphs & Charts @ 

Data Bridge Market Research analyses that the animal livestock drugs market was valued at USD 33.939 billion in 2021 and is expected to reach USD 51.69 billion by 2029, registering a CAGR of 5.40% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Except for poultry, animal livestock refers to farmed ruminants and domestic animals. Cattle, goats, sheep, donkeys, pigs, horses, and other animals are the most common members of this class, but different animals may predominate in other areas’ agriculture. The largest livestock group in the world is cattle (genus bos). Sheep of the genus ovis were among the first domesticated animals.


  • Increasing prevalence of zoonotic and food-borne diseases

The market is mostly driven by an increase in the global prevalence of zoonotic and food-borne diseases and a major increase in demand for protein diet. Companies are racing to develop new vaccinations and medications in response to this extraordinary spike in disease prevalence. Because of the increasing demand, there has been an increase in the number of companies making regular efforts to control pathogen contamination concerns and food-borne diseases, which is helping to drive market expansion.

  • Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of animal livestock drugs market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the animal livestock drugs market. Additionally, increasing penetration of pet insurance and surging demand for online veterinary pharmacies will expand the animal livestock drugs market.


  • Increase in the number of research and development activities       

Moreover, the market’s growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the animal livestock drugs market growth. Along with this, rising drug approvals and launches will further propel the market’s growth rate.

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the animal livestock drugs market growth during the forecast period.

Request For TOC @

The geographic regions and countries covered in the study include:

The countries covered in the animal livestock drugs market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the animal livestock drugs market because of the growing level of investment for research activities and rising healthcare expenditure in this region. Additionally, the presence of major key players will further propel the market’s growth rate in this region.

Asia-Pacific are expected to grow during the forecast period of 2022 to 2029 due to growing government awareness programs in this region. Also, development of healthcare infrastructure and surging number of generic drugs will further propel the market’s growth rate in this region.

Inquiry before Buying the Report @

Global Animal Livestock Drugs Market Scope

The animal livestock drugs market is segmented on the basis of type, product, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.


  • Cattle
  • Sheep
  • Pigs
  • Goats
  • Horses
  • Others


  • Drugs
  • Antiparasitic
  • Anti-inflammatory
  • Anti-infectives
  • Vaccines
  • Modified Live Vaccines [MLV]
  • Killed Inactivated Vaccines
  • Medicated Feed Additives
  • Antibiotics
  • Vitamins
  • Amino Acids
  • Enzymes
  • Antioxidants
  • Prebiotics and Probiotics
  • Minerals


  • Veterinary Hospitals
  • Veterinary Specialty Clinics
  • Others

Distribution Channel

  • Veterinary Hospital Pharmacy
  • Retail Pharmacy
  • Veterinary Research Institute
  • Others

Access Full Report:

This study answers to the below key questions:

1 What will the market size be in 2029?

2 What are the key factors driving the Animal Livestock Drugs Market?

3 What are the challenges to market growth?

4 Who are the key players in the Animal Livestock Drugs Market?

5 What are the market opportunities and threats faced by the key players?

Top Trending Reports:

About Data Bridge Market Research:                         

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.


Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Editor Details

  • Company:
    • The Wire Times
Last Updated: 23-Nov-2022